ObjectiveTo assess relationship between alexithymia and acne vulgaris in young people.MethodsA hundred and eleven subjects between 15 and 25 years of age referred to out-patient clinic of dermatology with acne and 78 subjects applied to family physician for complaints other than acne were included in patient and control groups of the study, respectively. A questionnaire to determine demographic characteristics, an acne classification to determine severity of acne and Toronto Alexithymic Scale (TAS) to assess alexithymia were used.ResultsThe mean scores of TAS were 52.7±10.8 and 51.7±10.7 in patient and control groups, respectively. Alexitymia was determined in 23.4% of the subjects in acne group and in 24.4% of control group. No significant differences were found between groups in terms of alexithymia, intermediate alexitymia and three-factors of TAS.ConclusionAlexithymia does not appear to be related to acne vulgaris.
This study is distinctive since it is the first study to determine the eliciting role of ACD on DLE by imposing standard and cosmetic patch test series on DLE and control group patients. Worldwide, there is no study based on this subject. In the DLE group, the results of sensitization on standard and cosmetic patch test series were higher and statistically significant. Larger studies are required to reveal the exact role.
ÖzetTufted folikülit (TF), saçlı derinin, tek bir folikül ağzından çok sayıda kılın çıkışı ve skatrisyel alopesi ile karakterize, kronik, ilerleyici, inflamatuvar bir hastalığıdır. On dört yaşında, kız çocuk, on yıldır devam eden saçlı deride akıntılı, kaşıntılı, iltihabi yaralar şikayetiyle polikliniğimize başvurdu. Dermatolojik muayenede, saçlı deride paryeto-oksipital bölgede, 15x25 cm boyutlarında, sklerotik plak zemininde, her bir dilate folikül ağzından 10-15 adet normal saçın dışarı çıktığı gözlendi. Histopatolojik inceleme ile TF tanısı kondu. Hastaya, 3 hafta boyunca verilen 600 mg/gün rifampisin, 1500 mg/gün sefaleksin, 1000 mg/gün vitamin C tedavisi etkili olmadı. Sonrasında 0,5 mg/kg/gün isotretinoin 6 ay süreyle verildi. Bu tedavi ile saçlı derideki inflamasyon ve eksudasyon azalırken, kümeleşmiş saçlar sebat ediyordu. TF tanısı konan bu olgu nadir görülmesi nedeniyle sunulmakta ve tedavisindeki güçlükler üzerinde durulmaktadır. (Türk derm 2013; 47: 120-2) Anah tar Ke li me ler: Tufted folikülit, isotretinoin, rifampisin, tedavi Sum maryTufted hair folliculitis (THF) is a recurrent and progressive folliculitis of the scalp that resolves with irregular areas of scarring alopecia within which numerous hair tufts emerge from dilated follicular openings. A 14-year-old female presented with pruritic, inflammatory and exudating wounds on the scalp which appeared ten years ago. Dermatological examination revealed tufts of 10 to 15 apparently normal hair shafts in a sclerotic plaque measuring 15x25 cm on the parieto-occipital region of the scalp that emerge through dilated follicular openings. The patient was diagnosed by histopathological examination as having THF. Oral rifampicin 600 mg/day, cephalexin 1500 mg/day and vitamin C 1000 mg/day for 3 weeks were not effective, then, he was treated with isotretinoin 0.6 mg/kg/day for six months. The inflammation and exudation decreased by this treatment while hair tufting was persisting. We report this case since THF is rarely encountered disease and is difficult to be treated. (Turkderm 2013; 47: 120-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.